MauriD., PavlidisN., IoannidisJ.P.: Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Ist, 97: 188–194, 2005.
2.
RastogiP., AndersonS.J., BearH.D., GeyerC.E., KahlenbergM.S., RobidouxA., MargoleseR.G., HoehnJ.L., VogelV.G., DakhilS.R., TamkusD., KingK.M., PajonE.R., WrightM.J., RobertJ., PaikS., MamounasE.P., WolmarkN.: Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol, 26: 778–785, 2008.
3.
WolmarkN., WangJ., MamounasE., BryantJ., FisherB.: Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr, 30: 96–102, 2001.
4.
AllisS., RealiA., MortellaroG., ArcadipaneF., BartonciniS., Ruo ReddaM.G.: Should radiotherapy after primary systemic therapy be administered with the same recommendations made for operable breast cancer patients who receive surgery as first treatment? A critical review. Tumori, 98: 543–549, 2012.
5.
OvergaardM., NielsenH.M., OvergaardJ.: Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol, 82: 247–253, 2007.
6.
MamounasE., AndersonS.J., DignamJ.J., BearH.D., JulianT.B., GeyerCEJr, TaghianA., WickerhamD.L., WolmarkN.: Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. J Clin Oncol, 30: 3960–3966, 2012.
7.
WhiteJ., MamounasE.: Locoregional radiotherapy in patients with breast cancer responding to neoadjuvant chemotherapy: a paradigm for treatment individualization. J Clin Oncol, 32: 494–495, 2014.
